Eiger BioPharmaceuticals, Inc. (EIGR) Operating Margin % [USD] 2021 - 2022

Historical data

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Eiger BioPharmaceuticals, Inc. annual/quarterly Operating Margin history and growth rate from 2021 to 2022.
  • Eiger BioPharmaceuticals, Inc. Operating Margin for the quarter ending December 31, 2022 was -688 %, a 8.54% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Operating Margin for 2023 was -455 %, a 33.8% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Operating Margin for 2022 was -688 %, a 8.54% decline from 2021.
Operating Margin, Quarterly (% [USD])
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -688 -54.1 -8.54% Oct 1, 2022 Dec 31, 2022
Q3 2022 -630 Jul 1, 2022 Sep 30, 2022
Q2 2022 -643 Apr 1, 2022 Jun 30, 2022
Q1 2022 -743 Jan 1, 2022 Mar 31, 2022
Q4 2021 -634 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.